As part of Chile`s investment in biotechnology research and innovation, the Blue Genomics Chile was officially opened by CORFO`s CEO Hernán Cheyres.

Aqua Gen is about to install a new automated production line that ensures a standardized and optimal treatment and fertilization of the newly stripped eggs. The reason for this development is the need for increased capacity and gentler handling of the eggs in the production of sterile fish.

The Directorate of Fisheries has issued licenses to five fish farming companies for testing of large-scale production of sterile salmon under commercial conditions. Aqua Gen is in charge of egg production and is also, together with Institute of Marine Research (IMR,) responsible for the project.

A group of shareholders consisting of Skretting Investment AS, Marine Harvest Norway AS, Marine Harvest Holding AS and Cermaq ASA has accepted a bid from EW Group GmbH for their total holding of 42.6 % of the shares in Aqua Gen AS.